Literature DB >> 6331167

Skin test with varicella-zoster virus antigen for ophthalmic herpes zoster.

Y Tanaka, S Harino, S Danjo, J Hara, K Yamanishi, M Takahashi.   

Abstract

We assessed delayed dermal hypersensitivity to varicella-zoster virus by a varicella skin test in 12 patients (nine women and three men ranging in age from 27 to 85 years) with ophthalmic herpes zoster during the acute stage and in a group of 27 healthy controls (15 women and 12 men ranging in age from 18 to 58 years). Of the 27 healthy individuals, 25 had positive skin test reactions whereas only one of the 12 patients with ophthalmic herpes zoster had a positive skin test reaction within two weeks after the onset of the eruption, suggesting that cellular immunity to varicella-zoster virus antigens is impaired in the development of ophthalmic herpes zoster. Our study also showed that the varicella skin test is a convenient way to diagnose ophthalmic herpes zoster during the acute stage of the disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331167     DOI: 10.1016/0002-9394(84)90180-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  An intradermal skin test for determination of immunity to varicella.

Authors:  E Somekh; Y Bujanover; G Tal; I Dalal; A Tanay; D Lehman
Journal:  Arch Dis Child       Date:  2001-12       Impact factor: 3.791

2.  Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections.

Authors:  K Baba; K Shiraki; T Kanesaki; K Yamanishi; P L Ogra; H Yabuuchi; M Takahashi
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

3.  Assessment of skin test with varicella-zoster virus antigen for predicting the risk of herpes zoster.

Authors:  Y Okuno; Y Takao; Y Miyazaki; F Ohnishi; M Okeda; S Yano; H Kumihashi; Y Gomi; K Maeda; T Ishikawa; Y Mori; H Asada; H Iso; K Yamanishi
Journal:  Epidemiol Infect       Date:  2012-12-10       Impact factor: 4.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.